A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastasesNicola S. Meagher, Raghwa Sharma, Linyuan Wang et al.|Modern Pathology|2019Cited by 104
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriersAntonis C. Antoniou, Tomasz Huzarski, Liliana Varesco et al.|Human Molecular Genetics|2011Cited by 77
Common Variants at the 19p13.1 and <i>ZNF365</i> Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Mutation CarriersFergus J. Couch, Theo A. van Os, Mia M. Gaudet et al.|Cancer Epidemiology Biomarkers & Prevention|2012Cited by 57
Validated biomarker assays confirm that <scp>ARID1A</scp> loss is confounded with <scp>MMR</scp> deficiency, <scp> CD8 <sup>+</sup> TIL </scp> infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomasKarolin Heinze, Yurii B. Shvetsov, Tayyebeh M. Nazeran et al.|The Journal of Pathology|2021Cited by 42
Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian CarcinomaKarolin Heinze, Yurii B. Shvetsov, Tayyebeh M. Nazeran et al.|medRxiv|2021Cited by 4